DALLAS, TX--(Marketwired - Apr 15, 2014) - The Traders Network Show Broadcasted live Daily on Clear Channel Business Talk Radio announced today that Andrew Whelan CEO of BioElectronics Corporation (
Archived Segment 1: (10min, 01sec)
http://www.yorbamedia.com/images/stories/audio/TN032614SEG3.mp3
Archived Segment 2: (9min, 35sec)
http://www.yorbamedia.com/images/stories/audio/TN032614SEG4.mp3
Network: Clear Channel
Station: DFW 1190AM KFXR Dallas-Ft. Worth
Host: Michael Yorba
Interview Highlights:
In this two segment exclusive with CEO Andrew J. Whelan he talked about how BIEL competitive advantage over traditional over the counter drugs, BIEL market position and how and why the body reacts to pain. "The body is regulated by electrical signals and that essentially their technology modifies those signals to reduce pain, inflammation, and accelerate healing using pulse short wave therapy. Said Whelan
"Our devices send radio signal into tissues, the pulsing causes a muscle response, gets the blood flowing and the blood flow clears out the inflammation and reduces the pain. We have the only real solution to pain. Narcotic drugs don't heal. Our product heals the tissue. Clinically proven pain and inflammation relief at the source. 5x better compared to over-the-counter drugs. Plus our product is 100% safe"
He went on to talk more about their OTC product The ActiPatch. This therapy is a significant opportunity and presented by one of the most common human ailments, namely, musculoskeletal complaints. This is especially true regarding the substantial market for treating back pain. Additional product opportunities exist to treat sore necks, knees, tennis elbow, heels, and wrist pain.
During the second half of the interview Yorbal asked Whalen to describe the rest of their product line. Along with the Actipatch which is OTC, for Musculoskeletal Pain Relief they have products for foot/heal care, menstrual pain relief, Postoperative Pain & Edema Recovery & Pain Management, and Veterinary Pain Relief.
To hear the entire interview click on the archive links above.
About Clear Channel: Clear Channel's Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.
About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm - 3pm CT, Monday-Friday.
About The Traders Network Show -- Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It's a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more... shift your thinking and join us as we deliver "tomorrow's ideas today" on Clear Channel's "The Traders Network Show".
About BioElectronics Corporation -- BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy; and HealFast® Therapy for dogs, cats and horses. For more information, please visit www.bielcorp.com.
A www.1800PublicRelations.com PR Event
Contact Information:
Contact:
BIEL
Paul Knopick
+1 (940) 262-3584
pknopick@eandecommunications.com
Press/Media
Matthew Bird
President
MUNCmedia Public Relations
+1 (917) 409-8211
matt.bird@muncmedia.com
www.muncmedia.com